You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

  1. Home
  2. Clinical Information
  3. Performance Measures
  4. Hospital Acquired Infections

Hospital Acquired Infections

    Do Not Support: Uncertain Validity
    • Facility
    • Population: Regional and State

    National Healthcare Safety Network Facility-Wide Inpatient Hospital-Onset Clostridium Difficile (CDI) Outcome Measure

    Standardized infection ratio (SIR) and Adjusted Ranking Metric (ARM) of hospital-onset CDI Laboratory-identified events (LabID events) among all inpatients in the facility, excluding well-baby nurseries and neonatal intensive care units (NICUs).

    Date Reviewed: July 21, 2018

    Support
    • Facility
    • Population: Regional and State

    National Healthcare Safety Network Facility-Wide Inpatient Hospital Onset MRSA Bacteremia Outcome

    Standardized infection ratio (SIR) and Adjusted Ranking Metric (ARM) of hospital-onset unique blood source MRSA Laboratory-identified events (LabID events) among all inpatients in the facility.

    Date Reviewed: July 21, 2018

    Support
    • Facility
    • Population: Regional and State

    National Healthcare Safety Network Central Line-Associated Blood Stream Infection (CLABSI) Outcome Measure

    Standardized Infection Ratio (SIR) and Adjusted Ranking Metric (ARM) of healthcare-associated, central line-associated bloodstream infections (CLABSI) will be calculated among patients in bedded inpatient care locations. This includes acute care general hospitals, long-term acute care hospitals, rehabilitation hospitals, oncology hospitals, and behavioral health hospitals.

    Date Reviewed: July 21, 2018

    Do Not Support: Uncertain Validity
    • Facility
    • Population: Regional and State

    National Healthcare Safety Network Catheter Associated Urinary Tract Infection (CAUTI)

    Standardized Infection Ratio (SIR) of healthcare-associated, catheter-associated urinary tract infections (UTI) will be calculated among patients in bedded inpatient care locations, except level II or level III neonatal intensive care units (NICU). This includes acute care general hospitals, long-term acute care hospitals, rehabilitation hospitals, oncology hospitals, and behavior health hospitals.

    Date Reviewed: July 21, 2018

    Do Not Support
    • Facility

    National Healthcare Safety Network Antimicrobial Use Measure

    This measure assesses antimicrobial use in hospitals based on medication administration data that hospitals collect electronically at the point of care and report via electronic file submissions to CDC’s National Healthcare Safety Network (NHSN). The antimicrobial use data that are in scope for this measure are antibacterial agents administered to adult and pediatric patients in a specified set of ward and intensive care unit locations: medical, medical/surgical, and surgical wards and units. The measure compares antimicrobial use that the hospitals report with antimicrobial use that is predicted on the basis of nationally aggregated data. The measure is comprised of a discrete set of ratios, Standardized Antimicrobial Administration Ratios (SAARs), each of which summarizes observed-to-predicted antibacterial use for one of 16 antibacterial agent-patient care location combinations. The SAARs are designed to serve as high value targets or high level indicators for antimicrobial stewardship programs (ASPs). SAAR values that are outliers are intended to prompt analysis of possible overuse, underuse, or inappropriate use of antimicrobials, subsequent actions aimed at improving the quality of antimicrobial prescribing, and impact evaluations of ASP interventions.

    Date Reviewed: July 21, 2018